- Home
- IPHA vs VIOT Comparison
IPHA vs VIOT Comparison
Compare IPHA & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | VIOT |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | France | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 192.3M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IPHA | VIOT |
|---|---|---|
| Price | $1.85 | $2.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 258.3K |
| Earning Date | 09-17-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | $14,839,695.00 | ★ $385,267,177.00 |
| Revenue This Year | $22.29 | $42.19 |
| Revenue Next Year | $43.90 | $0.96 |
| P/E Ratio | ★ N/A | $5.98 |
| Revenue Growth | N/A | ★ 16.89 |
| 52 Week Low | $1.47 | $1.21 |
| 52 Week High | $3.51 | $4.33 |
Technical Indicators
Market Signals| Indicator | IPHA | VIOT |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 37.90 |
| Support Level | $1.85 | $2.23 |
| Resistance Level | $1.92 | $2.39 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 25.58 | 16.67 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.